GPN0-1530

N/A

Report date: 2025/12/19 17:00:13
NME

Base Information

Drug NameGPN0-1530
Drug Alias NameGPN01530GPN0-1530
ClassificationRadiation-emitting products > Radionuclide Drug ConjugatesSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast activation protein alpha modulators
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGrand Pharmaceutical （China） Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGrand Pharmaceutical （China） Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A